Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital 12 de Octubre i+12, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain; CIBER de Bioingeniería Biomateriales y Nanomedicina (CIBER-BBN), Spain.
Université de Nantes, CNRS, UMR 6230, CEISAM, UFR Sciences et Techniques, 2 Rue de la Houssinière, 44322 NANTES Cedex 3, France.
Acta Biomater. 2018 Aug;76:333-343. doi: 10.1016/j.actbio.2018.06.036. Epub 2018 Jun 30.
Mesoporous bioactive glasses (MBGs) in the system SiO-CaO-PO-GaO have been synthesized by the evaporation induced self-assembly method and subsequent impregnation with Ga cations. Two different compositions have been prepared and the local environment of Ga(III) has been characterized using Si, Ga and P NMR analysis, demonstrating that Ga(III) is efficiently incorporated as both, network former (GaO units) and network modifier (GaO units). In vitro bioactivity tests evidenced that Ga-containing MBGs retain their capability for nucleation and growth of an apatite-like layer in contact with a simulated body fluid with ion concentrations nearly equal to those of human blood plasma. Finally, in vitro cell culture tests evidenced that Ga incorporation results in a selective effect on osteoblasts and osteoclasts. Indeed, the presence of this element enhances the early differentiation towards osteoblast phenotype while disturbing osteoclastogenesis. Considering these results, Ga-doped MBGs might be proposed as bone substitutes, especially in osteoporosis scenarios.
Osteoporosis is the most prevalent bone disease affecting millions of patients every year. However, there is a lack of bone grafts specifically designed for the treatment of bone defects occurred because of osteoporotic fractures. The consequence is that osteoporotic bone defects are commonly treated with the same biomaterials intended for high quality bone tissue. In this work we have prepared mesoporous bioactive glasses doped with gallium, demonstrating osteoinductive capability by promoting the differentiation of pre-osteoblast toward osteoblasts and partial inhibition of osteoclastogenesis. Through a deep study of the local environment of gallium within the mesoporous matrix, this work shows that gallium release is not required to produce this effect on osteoblasts and osteoclasts. In this sense, the presence of this element at the surface of the mesoporous bioactive glasses would be enough to locally promote bone formation while reducing bone resorption.
通过蒸发诱导自组装方法和随后的 Ga 阳离子浸渍合成了 SiO-CaO-PO-GaO 系统中的介孔生物活性玻璃(MBG)。制备了两种不同的组成,并使用 Si、Ga 和 P NMR 分析对 Ga(III)的局部环境进行了表征,证明 Ga(III)作为网络形成剂(GaO 单元)和网络改性剂(GaO 单元)被有效掺入。体外生物活性测试表明,含 Ga 的 MBG 在与具有接近人血浆离子浓度的模拟体液接触时保持其成核和生长类骨质层的能力。最后,体外细胞培养测试表明,Ga 的掺入对成骨细胞和破骨细胞有选择性作用。事实上,这种元素的存在增强了向成骨细胞表型的早期分化,同时干扰了破骨细胞的生成。考虑到这些结果,Ga 掺杂的 MBG 可能被提议作为骨替代品,特别是在骨质疏松症的情况下。
骨质疏松症是影响每年数百万人的最常见骨骼疾病。然而,缺乏专门设计用于治疗因骨质疏松性骨折而发生的骨缺损的骨移植物。结果是,骨质疏松性骨缺损通常用相同的生物材料治疗,这些生物材料旨在用于高质量的骨组织。在这项工作中,我们制备了掺杂 Ga 的介孔生物活性玻璃,通过促进前成骨细胞向成骨细胞的分化和部分抑制破骨细胞生成,证明了其具有成骨能力。通过对 Ga 在介孔基质中的局部环境进行深入研究,本工作表明,Ga 的释放不是产生这种对成骨细胞和破骨细胞作用所必需的。在这种意义上,介孔生物活性玻璃表面存在这种元素就足以局部促进骨形成,同时减少骨吸收。